Bleeding outcomes associated with rivaroxaban and dabigatran in patients treated for atrial fibrillation: a systematic review and meta-analysis

Table 3 Baseline features

Studies	Mean age	Males (%)	Ht (%)	Ds (%)	Cs (%)	DM (%)
	R/D	R/D	R/D	R/D	R/D	R/D
Gorst 2016 [8] Larock 2014 [9] Maura 2015 [10] Providencia 2014 [11] Sherid 2014 [12]	77.8/73.4 73.0/75.0 73.6/74.0 60.1/59.8 68.3/72.7	45.7/53.4 62.0/66.0 55.0/54.0 73.9/75.1 47.6/50.2	36.8/32.1 71.0/71.0 78.0/80.0 39.4/30.1 -	- - 47.0/47.0 - -	- - 3.0/4.0 - -	15.6/13.5 20.0/20.0 19.0/19.0 9.0/6.3 -

Abbreviations: R rivaroxaban, D dabigatran, Ht hypertension, Ds dyslipidemia, Cs current smoker, DM diabetes mellitus

ISSN: 1471-2261